Exciting News: Bullfrog AI Successfully Completes Registered Direct Offering and Private Placement, Raising $3.13 Million!

Welcome to the Future of Drug Development Today, October 21, 2024, BullFrog AI Holdings, Inc. has made a groundbreaking announcement that is set to revolutionize the field of pharmaceuticals and biologics. The company, known for its innovative use of artificial intelligence and machine learning, has closed a definitive agreement for the purchase and sale of…

Read More

Unraveling the Catalyst: Understanding the Key Factors Fueling Catalyst Pharmaceuticals’ Stock Surge

Catalyst Pharmaceuticals: A Surprising Q4 Earnings Report Boosts Stock Price Shares of Catalyst Pharmaceuticals, Inc. (CPRX) have seen a notable increase in value during Thursday’s trading session, with the stock price up by over 8% as of midday. This uptick comes after the drugmaker reported its fourth-quarter financial results, which surpassed analysts’ expectations. Better-than-Expected Earnings…

Read More

Bronstein, Gewirtz & Grossman, LLC Initiates Investigation: A Closer Look at the Company Under Scrutiny

Bronstein, Gewirtz & Grossman, LLC: Investigating Potential Claims Against enCore Energy Corp New York, NY – In a recent press release on March 16, 2025, Bronstein, Gewirtz & Grossman, LLC, a leading national securities fraud law firm, announced that it is investigating potential claims on behalf of purchasers of enCore Energy Corp (“enCore” or “the…

Read More